98 related articles for article (PubMed ID: 9346826)
21. Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformation.
Fouts DE; True HL; Cengel KA; Celander DW
Biochemistry; 1997 Oct; 36(43):13256-62. PubMed ID: 9341215
[TBL] [Abstract][Full Text] [Related]
22. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
23. Retroviruses as model systems for the study of nuclear RNA export pathways.
Cullen BR
Virology; 1998 Sep; 249(2):203-10. PubMed ID: 9791012
[No Abstract] [Full Text] [Related]
24. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.
Daelemans D; Afonina E; Nilsson J; Werner G; Kjems J; De Clercq E; Pavlakis GN; Vandamme AM
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14440-5. PubMed ID: 12374846
[TBL] [Abstract][Full Text] [Related]
25. Tolerance of diverse amino acid substitutions at conserved positions in the nuclear export signal (NES) of HIV-1 Rev.
Zhang MJ; Dayton AI
Biochem Biophys Res Commun; 1998 Feb; 243(1):113-6. PubMed ID: 9473489
[TBL] [Abstract][Full Text] [Related]
26. Rev protein suppression of complex formation between nuclear proteins and rev-responsive element-containing RNA of human immunodeficiency virus-1.
Bek A; Müller WE; Sève AP; Kavsan V; Schröder HC
Int J Biochem Cell Biol; 1995 Dec; 27(12):1317-29. PubMed ID: 8581828
[No Abstract] [Full Text] [Related]
27. In silico mutagenesis of RNA splicing in HIV-1.
Kim H; Yin J
Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
[TBL] [Abstract][Full Text] [Related]
28. The structure of the HIV-1 RRE high affinity rev binding site at 1.6 A resolution.
Ippolito JA; Steitz TA
J Mol Biol; 2000 Jan; 295(4):711-7. PubMed ID: 10656783
[TBL] [Abstract][Full Text] [Related]
29. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of backbone cyclic peptides bearing the arm domain of the HIV-1 Rev protein: characterization of the karyophilic properties and inhibition of Rev-induced gene expression.
Hariton-Gazal E; Rosenbluh J; Zakai N; Fridkin G; Brack-Werner R; Wolff H; Devaux C; Gilon C; Loyter A
Biochemistry; 2005 Aug; 44(34):11555-66. PubMed ID: 16114892
[TBL] [Abstract][Full Text] [Related]
31. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
[TBL] [Abstract][Full Text] [Related]
32. Specific RNA binding proteins constructed from zinc fingers.
Friesen WJ; Darby MK
Nat Struct Biol; 1998 Jul; 5(7):543-6. PubMed ID: 9665165
[TBL] [Abstract][Full Text] [Related]
33. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
34. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
Modem S; Reddy TR
J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
[TBL] [Abstract][Full Text] [Related]
35. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.
Stauber RH; Afonina E; Gulnik S; Erickson J; Pavlakis GN
Virology; 1998 Nov; 251(1):38-48. PubMed ID: 9813201
[TBL] [Abstract][Full Text] [Related]
36. Recombinant technology as an alternative to chemical peptide synthesis: expression and characterization of HIV-1 Rev recombinant peptides.
Lepage P; Heckel C; Humbert S; Stahl S; Rautmann G
Anal Biochem; 1993 Aug; 213(1):40-8. PubMed ID: 8238880
[TBL] [Abstract][Full Text] [Related]
37. 1H NMR studies of the high-affinity Rev binding site of the Rev responsive element of HIV-1 mRNA: base pairing in the core binding element.
Peterson RD; Bartel DP; Szostak JW; Horvath SJ; Feigon J
Biochemistry; 1994 May; 33(18):5357-66. PubMed ID: 8180157
[TBL] [Abstract][Full Text] [Related]
38. Solid-state NMR data support a helix-loop-helix structural model for the N-terminal half of HIV-1 Rev in fibrillar form.
Blanco FJ; Hess S; Pannell LK; Rizzo NW; Tycko R
J Mol Biol; 2001 Nov; 313(4):845-59. PubMed ID: 11697908
[TBL] [Abstract][Full Text] [Related]
39. Structure of the HIV-1 Rev response element alone and in complex with regulator of virion (Rev) studied by atomic force microscopy.
Pallesen J; Dong M; Besenbacher F; Kjems J
FEBS J; 2009 Aug; 276(15):4223-32. PubMed ID: 19583776
[TBL] [Abstract][Full Text] [Related]
40. Direct RNA binding by the rev product of HIV-1.
Walley AJ; Heaphy S; Jones IM
AIDS; 1989 Dec; 3(12):859-61. PubMed ID: 2517208
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
